Genetic data: The new challenge of personalized medicine, insights for rheumatoid arthritis patients

George N. Goulielmos, Maria I. Zervou, Effie Myrthianou, Agata Burska, Timothy B. Niewold, Frederique Ponchel

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Rapid advances in genotyping technology, analytical methods, and the establishment of large cohorts for population genetic studies have resulted in a large new body of information about the genetic basis of human rheumatoid arthritis (RA). Improved understanding of the root pathogenesis of the disease holds the promise of improved diagnostic and prognostic tools based upon this information. In this review, we summarize the nature of new genetic findings in human RA, including susceptibility loci and gene-gene and gene-environment interactions, as well as genetic loci associated with sub-groups of patients and those associated with response to therapy. Possible uses of these data are discussed, such as prediction of disease risk as well as personalized therapy and prediction of therapeutic response and risk of adverse events. While these applications are largely not refined to the point of clinical utility in RA, it seems likely that multi-parameter datasets including genetic, clinical, and biomarker data will be employed in the future care of RA patients.

Original languageEnglish (US)
JournalGene
DOIs
StateAccepted/In press - Oct 31 2015

Fingerprint

Precision Medicine
Rheumatoid Arthritis
Gene-Environment Interaction
Genetic Loci
Medical Genetics
Population Genetics
Genes
Therapeutics
Biomarkers
Technology

Keywords

  • Gene polymorphisms
  • Genotyping technologies
  • Personalized medicine
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Genetics

Cite this

Goulielmos, G. N., Zervou, M. I., Myrthianou, E., Burska, A., Niewold, T. B., & Ponchel, F. (Accepted/In press). Genetic data: The new challenge of personalized medicine, insights for rheumatoid arthritis patients. Gene. https://doi.org/10.1016/j.gene.2016.02.004

Genetic data : The new challenge of personalized medicine, insights for rheumatoid arthritis patients. / Goulielmos, George N.; Zervou, Maria I.; Myrthianou, Effie; Burska, Agata; Niewold, Timothy B.; Ponchel, Frederique.

In: Gene, 31.10.2015.

Research output: Contribution to journalArticle

Goulielmos, George N. ; Zervou, Maria I. ; Myrthianou, Effie ; Burska, Agata ; Niewold, Timothy B. ; Ponchel, Frederique. / Genetic data : The new challenge of personalized medicine, insights for rheumatoid arthritis patients. In: Gene. 2015.
@article{dc8a0e8cb19c447988f8373555fd429a,
title = "Genetic data: The new challenge of personalized medicine, insights for rheumatoid arthritis patients",
abstract = "Rapid advances in genotyping technology, analytical methods, and the establishment of large cohorts for population genetic studies have resulted in a large new body of information about the genetic basis of human rheumatoid arthritis (RA). Improved understanding of the root pathogenesis of the disease holds the promise of improved diagnostic and prognostic tools based upon this information. In this review, we summarize the nature of new genetic findings in human RA, including susceptibility loci and gene-gene and gene-environment interactions, as well as genetic loci associated with sub-groups of patients and those associated with response to therapy. Possible uses of these data are discussed, such as prediction of disease risk as well as personalized therapy and prediction of therapeutic response and risk of adverse events. While these applications are largely not refined to the point of clinical utility in RA, it seems likely that multi-parameter datasets including genetic, clinical, and biomarker data will be employed in the future care of RA patients.",
keywords = "Gene polymorphisms, Genotyping technologies, Personalized medicine, Rheumatoid arthritis",
author = "Goulielmos, {George N.} and Zervou, {Maria I.} and Effie Myrthianou and Agata Burska and Niewold, {Timothy B.} and Frederique Ponchel",
year = "2015",
month = "10",
day = "31",
doi = "10.1016/j.gene.2016.02.004",
language = "English (US)",
journal = "Gene",
issn = "0378-1119",
publisher = "Elsevier",

}

TY - JOUR

T1 - Genetic data

T2 - The new challenge of personalized medicine, insights for rheumatoid arthritis patients

AU - Goulielmos, George N.

AU - Zervou, Maria I.

AU - Myrthianou, Effie

AU - Burska, Agata

AU - Niewold, Timothy B.

AU - Ponchel, Frederique

PY - 2015/10/31

Y1 - 2015/10/31

N2 - Rapid advances in genotyping technology, analytical methods, and the establishment of large cohorts for population genetic studies have resulted in a large new body of information about the genetic basis of human rheumatoid arthritis (RA). Improved understanding of the root pathogenesis of the disease holds the promise of improved diagnostic and prognostic tools based upon this information. In this review, we summarize the nature of new genetic findings in human RA, including susceptibility loci and gene-gene and gene-environment interactions, as well as genetic loci associated with sub-groups of patients and those associated with response to therapy. Possible uses of these data are discussed, such as prediction of disease risk as well as personalized therapy and prediction of therapeutic response and risk of adverse events. While these applications are largely not refined to the point of clinical utility in RA, it seems likely that multi-parameter datasets including genetic, clinical, and biomarker data will be employed in the future care of RA patients.

AB - Rapid advances in genotyping technology, analytical methods, and the establishment of large cohorts for population genetic studies have resulted in a large new body of information about the genetic basis of human rheumatoid arthritis (RA). Improved understanding of the root pathogenesis of the disease holds the promise of improved diagnostic and prognostic tools based upon this information. In this review, we summarize the nature of new genetic findings in human RA, including susceptibility loci and gene-gene and gene-environment interactions, as well as genetic loci associated with sub-groups of patients and those associated with response to therapy. Possible uses of these data are discussed, such as prediction of disease risk as well as personalized therapy and prediction of therapeutic response and risk of adverse events. While these applications are largely not refined to the point of clinical utility in RA, it seems likely that multi-parameter datasets including genetic, clinical, and biomarker data will be employed in the future care of RA patients.

KW - Gene polymorphisms

KW - Genotyping technologies

KW - Personalized medicine

KW - Rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=84958213733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958213733&partnerID=8YFLogxK

U2 - 10.1016/j.gene.2016.02.004

DO - 10.1016/j.gene.2016.02.004

M3 - Article

C2 - 26869316

AN - SCOPUS:84958213733

JO - Gene

JF - Gene

SN - 0378-1119

ER -